Blue Horseshoe Stocks: Afternoon Updates

AFTERNOON UPDATES

Vid3G, Inc. VIDG

We didn’t see the continuation of the uptrend on VIDG as we had hoped this morning, though its important to remember that plays coming off of their 52-week lows can take a little time to mature before they’re ready for a full recovery.

So we’ll still keep this one on our radar as the week continues, while it continues to feel out a bottom.

Med-Cannabis Pharma, Inc. MCPI

On a brighter note, our alert on MCPI yesterday came a really good time. We saw a low of .355 during Monday’s session, and today the stock continued to move, running as high as .465 this afternoon. That marked a solid 30% overnight increase on this marijuana related play.

Remember, this is one that we’ll have on watch for some time as the company prepares to open three recreational cannabis shops in Washington State. We’ll be eager for updates in that regard.

Blue Horseshoe Stocks: VIDG, PBR Calls & More

Vid3G, Inc. VIDG

We’re bringing VIDG up as an item of interest this morning as a stock that is coming off of its 52-week lows, and our subscribers are well aware, we’ve seen plays like these produce exponential gains on the rebound many times in the past.

Yesterday’s session saw a rapid swing up from that annual low (.01), and VIDG managed to break through its 50DMA at .015, as well as maintain that level into the close. Another session of higher highs and higher lows would go a long way toward confirming this uptrend. We’d like to see that previous area of resistance hold as support moving ahead, and based on a number of indicators on the chart, the chance for a bounce to .02 or better is certainly present; VIDG has produced spikes of that magnitude several times this year.

We illustrate this and other points on the chart in the following video, so take a look:

Petroleo Brasiliero S.A. (Petrobras) PBR – Options

On Friday, we mentioned our interest in the PBR $16 Calls for this week, and included a reminder in yesterday morning’s report as well. We’ve become quite adept at playing the PBR options chain over the last several months, and these alerts simply confirm that.

The action on the $16 Weekly Calls indeed proved to be significant as the trading week commenced, with yesterday’s session seeing an intraday move from .20-.38, good for gains of up to 90% A great way to kick things off for these contracts which are now in the money, and we’ll be sticking with the $16’s as the week presses on.

Should PBR approach the 16.35-level, we would then have to consider moving up our strike price.

IsoRay, Inc. ISR

We also want to throw ISR into the mix this morning, as the stock is gapping up off of a relative bottom on some exciting news this morning, so we wanted to enter this into the log as an interesting play that we’re going to want to keep an eye on.

RICHLAND, WA, Aug 05, 2014 (Marketwired via COMTEX) — IsoRay Inc. (NYSE MKT: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, today announced the publication of the first major peer reviewed study showing superior results using IsoRay’s Cesium-131 seeds in the treatment of metastatic brain cancer. >>>FULL PR

Extended Watchlist:
ODP, ESI, GRPN, MNI, KORS

Blue Horseshoe Stocks: CBDE, MCPI News & More

CBD Energy Ltd. CBDE

CBDE is a fairly new issuer, and built some serious momentum off of its bottom on Friday after the announcement of a lucrative solar farm construction contract. The company reports expected pre-tax revenues from the project amounting to more than $6 Million to be recognized in 2015, so we’re going to place this new stock on our medium-to-long term watchlist.

In the meantime, CBDE appears to be on the cusp of breaking the $4-mark this morning, which is the level at which the stock began trading just a couple of months ago. We’ll be watching for a breach of this psychological barrier, which would effectively put CBDE in Blue Sky mode, with no telling where the ceiling might come.

It should make for an interesting story to follow in the days and weeks ahead.

Med-Cannabis Pharma, Inc. MCPI

Turning focus to the marijuana space, we’ve got a new play to add to our running watchlist. It’s most interesting to us because it has a part to play in the implementation of legalization in Washington, which has been much more subdued than Colorado’s roll-out.

The madness that ensued thereafter led to months of record-breaking gains, but at the same time led to an SEC crackdown on what had become a free-for-all of false claims and hysteria. For that reason, companies involved in the more slowly unfolding Washington cannabis industry have been fewer and further between.

That’s exactly why we want to keep an eye on MCPI moving forward, despite the fact that it has already seen exponential gains; it’s confirmed that the company actually has boots on the ground in Washington, as indicated in this morning’s press release that we think you’ll want to check out:

PORT TOWNSEND, WA, Aug 04, 2014 (Marketwired via COMTEX) — Med-Cannabis Pharma, Inc. (OTCQB: MCPI), a Nevada Company specializing in Medical cannabis sales will be opening several Medical cannabis stores through its subsidiary Cannabis Hemporium in various towns on the Olympic Peninsula in the State of Washington during the month of August. The towns include Port Townsend, Port Hadlock and the Hood Canal location where work has been continuing for opening. >>> FULL PR

Side Note:

On Friday, we mentioned that we had an interest in PBR $16 Calls for this week, so we just wanted to remind readers that we would be focusing on those contracts as the trading week commences.

Extended Watchlist:
TSEM, NNVC, MEET, NQ, CAMT